Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Buhai Wang"'
Autor:
Zhijie Wang, Lin Wu, Baolan Li, Ying Cheng, Xiaoling Li, Xicheng Wang, Liang Han, Xiaohong Wu, Yun Fan, Yan Yu, Dongqing Lv, Jianhua Shi, Jianjin Huang, Shaozhang Zhou, Baohui Han, Guogui Sun, Qisen Guo, Youxin Ji, Xiaoli Zhu, Sheng Hu, Wei Zhang, Qiming Wang, Yuming Jia, Ziping Wang, Yong Song, Jingxun Wu, Meiqi Shi, Xingya Li, Zhigang Han, Yunpeng Liu, Zhuang Yu, An-Wen Liu, Xiuwen Wang, Caicun Zhou, Diansheng Zhong, Liyun Miao, Zhihong Zhang, Hui Zhao, Jun Yang, Dong Wang, Yingyi Wang, Qiang Li, Xiaodong Zhang, Mei Ji, Zhenzhou Yang, Jiuwei Cui, Beili Gao, Buhai Wang, Hu Liu, Lei Nie, Mei He, Shi Jin, Wei Gu, Yongqian Shu, Tong Zhou, Jian Feng, Xinmei Yang, Cheng Huang, Bo Zhu, Yu Yao, Xiongwen Tang, Jianjun Yu, Ellen Maher, Hui Feng, Sheng Yao, Patricia Keegan, Jie Wang
Publikováno v:
Journal of Clinical Oncology. 41:651-663
PURPOSE The CHOICE-01 study investigated the efficacy and safety of toripalimab in combination with chemotherapy as a first-line treatment for advanced non–small-cell lung cancer (NSCLC). PATIENTS AND METHODS Patients (N = 465) with treatment-naive
Autor:
Qing Zhou, Lin Wu, Jiuwei Cui, Bo Jiang, Yu Yao, Jian Zhang, Mingfang Zhao, Xiaorong Dong, Anwen Liu, Rui Ma, Yingying Du, Huijuan Wang, Buhai Wang, Xiaohua Hu, Hongming Pan, Haibo Zhang, Yiqiang Zhao, Yuan Meng, Andrew X. Zhu, Yi-Long Wu
Publikováno v:
Journal of Clinical Oncology. 40:e21123-e21123
e21123 Background: Upregulation of CD73 results in the adenosine overproduction, which suppresses immune responses in tumoral microenvironment. Uliledlimab (ULI), a differentiated anti-CD73 antibody, inhibits adenosine generation in a non-competitive
Autor:
Xue Meng, Anping Zheng, Jun Wang, Jianhua Wang, Guang Li, Jun Zhu, Hu Ma, Xiaodong Zhu, Anhui Shi, Chunhua Dai, Senxiang Yan, Buhai Wang, Zhongyu Qu, Chun Han, Xindong Sun, Ming Ye, Ruitai Fan, Ni yazi Huerxidan, Xiaohong Wang, Jinming Yu
Publikováno v:
Journal of Clinical Oncology. 40:4016-4016
4016 Background: 70% of esophageal carcinoma are unresectable at diagnosis. Despite active clinical research on the treatment of esophageal squamous cell carcinoma (ESCC), the long-term survival rate of advanced patients is still very low, with a 5-y
Publikováno v:
Journal of Global Oncology. 5:124-124
124 Background: To investigate the preservation of long-term neurocognitive function in patients after hippocampal avoidance whole-brain radiotherapy (HA-WBRT). Methods: For the retrospective analysis, 50 patients diagnosed with brain metastases were
Autor:
Xianglin Yuan, En Xiao Li, Jianming Xu, Xiang Li, Yunxin Chen, Buhai Wang, Huanli Wang, Yuxian Bai, Nong Xu
Publikováno v:
Journal of Clinical Oncology. 37:11-11
11 Background: Tislelizumab, a humanized IgG4 mAb with high affinity and specificity for PD-1, was specifically engineered to minimize FcγR binding on macrophages, thus abrogating antibody-dependent phagocytosis, a potential mechanism of T-cell clea